APSR2026-281

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP11-004
P46
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1217090-46904-APSR Abstract 2026-281 AP 11 004 V1_428509.pdf
Format: PDF Only
09. Asthma
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Vipula Bataduwaarachchi - Faculty of Medicine, University of Colombo, Sri Lanka. Department of Pharmacology Colombo Sri Lanka
Nathasha Dias - National Hospital, Colombo, Sri Lanka. Respiratory Medicine Unit Colombo Sri Lanka
Nayana Heendeniya - Faculty of Science, University of Colombo, Sri Lanka Department of Statistics Colombo Sri Lanka
Lakmali Amarasiri - Faculty of Medicine, University of Colombo, Sri Lanka. Department of Physiology Colombo Sri Lanka
Rishikesavan Suntharalingam * National Hospital, Colombo, Sri Lanka. Respiratory Medicine Unit Colombo Sri Lanka
Ravini Karunathilake - National Hospital, Colombo, Sri Lanka. Respiratory Medicine Unit Colombo Sri Lanka
 
 
 
 
 
 
 
 
 
Presenting Author Details
Rishikesavan
Suntharalingam
rishik95@yahoo.com
+940777275430
41-50
Sri Lanka
Original Research
Medicine usage and associated problems among an asthma patient cohort in a speciality asthma clinic at the National Hospital, Colombo, Sri Lanka
Maximum 25 words
Abstract Content
Asthma management in Sri Lanka is challenging due to the unavailability of essential medicines. Limited data is available on the use of medicines in the asthma clinic settings in Sri Lanka. This study aimed to assess the availability and accessibility of essential medicines, medication errors, and related problems among adult patients with asthma attending the asthma clinic at Respiratory Unit 2 of the National Hospital, Colombo, Sri Lanka.
A descriptive longitudinal study sampled consecutive adult patients attending the asthma clinic at the National Hospital of Sri Lanka over 5 months. Demographic and treatment-related data were captured using an interviewer-administered questionnaire. Data was analysed using the Statistical Package for the Social Sciences version 22.
Data from 250 patients were included. The patients (mean age of 50.67 (SD ± 17.46)) were mostly female (76%). Commonly used medications were short-acting beta-agonists (SABAs) (97.6%) and a long-acting beta-agonist (LABA) / inhaled corticosteroid (ICS) combination (90.4%). Of the patients, 9.6% were on SABA with ICS, and 1.6% were on a salmeterol/fluticasone combination without a SABA or a short-acting muscarinic antagonist, contrary to accepted global standards. Only 2% of patients were on formoterol/budesonide, and 1.6% of patients were on a SABA/ICS and long-acting muscarinic antagonist combination. Only two dose ranges were available for combined inhalers. Six (2.4%) patients were on montelukast. Neither formoterol/budesonide nor montelukast was continuously available in the hospital pharmacy.
The pattern of medicine use reflects the limited availability and accessibility of essential medicines required for optimal, up-to-date guideline-based asthma management. All essential medicines should be made available at least in tertiary care units. Non-standard treatment regimens indicate the need for continuing education of the medical and other staff involved in asthma care. This is an eye-opener for other resource-limited countries.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Asthma care, Medicine availability, Medicine accessibility
maximum 3 keywords and no abbreviations, separated by commas
None
297